Our mission is to discover molecular mechanisms underlying physiological and pathophysiological processes in the organism. This approach is the base for rational drug design, it serves target identification and target validation in modern pharmacological research. Thereby our research offers hope for defeating some of humanity’s most devastating diseases– cancer. The mission of the institute is to perform research and education in molecular, cellular, and clinical pharmacology.
Modern medicine relies on the correct, precise use of drugs. The development of novel therapeutics over the last decades enabled us to cure a wide range of diseases. Yet many aspects still prove difficult and are awaited to be solved! The greatest challenge of our time is to translate the knowledge gathered in this post-genomic era into practice for patient-tailored treatment options – a concept termed as Personalised or Precision Medicine. Pharmacology is not only committed to find out the mechanism of action of drugs but also assists in preparing and understanding how modern drugs can be optimally exploited for the benefit of each patient in the future.
- Scientific research
“Imagination is more important than knowledge, because knowledge is limited.” – Albert Einstein
- Representing the field of pharmacology and toxicology in education
“Before I came here, I was confused about this subject. Having listened to your lecture, I am still confused — but on a higher level.” – Enrico Fermi
- Providing our knowhow for the public
“Nothing in life is to be feared, it is only to be understood.” – Marie Curie
The Sexl Lab is located in the beautiful campus of the Vetmeduni Vienna, the only university in Austria focusing on veterinary medicine including animal and public health. About 1400 employees and 2300 students work on the campus. The Vetmeduni provides researchers and clinicians with a cutting-edge infrastructure to ensure excellence in research, teaching and animal health care.
Research topics go beyond veterinary medicine and include molecular medicine, pharmacology, biomedicine, biotechnology and bioinformatics. Since 2009 the Vetmeduni is involved in a number of FP7-, H2020- and ERA-Net projects as well as in projects financed by the European Structural Funds.
Besides heading an ERC-project, the Sexl Lab currently runs several national projects (FWF-stand alone projects, Herzfelder, Zukunftskolleg) and participates in a renowned SFB focusing on JAK/STAT and the epigenomic landscape.